These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16685397)

  • 41. Ephrin-B3 ligand promotes glioma invasion through activation of Rac1.
    Nakada M; Drake KL; Nakada S; Niska JA; Berens ME
    Cancer Res; 2006 Sep; 66(17):8492-500. PubMed ID: 16951161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities.
    Li M; Wang J; Ng SS; Chan CY; Chen AC; Xia HP; Yew DT; Wong BC; Chen Z; Kung HF; Lin MC
    Glia; 2008 Sep; 56(12):1328-38. PubMed ID: 18615633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Expression of pituitary tumor transforming gene, endostatin, and basic fibroblast growth factor mRNAs in invasive pituitary adenomas].
    Chen L; Liu YS; Wang LS; Yin HG; Hou QT; Liu ZX; Chen LH; Ling F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):651-3, 666. PubMed ID: 16114549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
    Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
    Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical expression of PTTG in brain tumors.
    Salehi F; Scheithauer BW; Sharma S; Kovacs K; Lloyd RV; Cusimano MD; Munoz DG
    Anticancer Res; 2013 Jan; 33(1):119-22. PubMed ID: 23267136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
    Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
    Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic impact of CD68 and kallikrein 6 in human glioma.
    Strojnik T; Kavalar R; Zajc I; Diamandis EP; Oikonomopoulou K; Lah TT
    Anticancer Res; 2009 Aug; 29(8):3269-79. PubMed ID: 19661345
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
    Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
    Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Over-expression of neuroepithelial-transforming protein 1 confers poor prognosis of patients with gliomas.
    Tu Y; Lu J; Fu J; Cao Y; Fu G; Kang R; Tian X; Wang B
    Jpn J Clin Oncol; 2010 May; 40(5):388-94. PubMed ID: 20304779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicopathologic significance of cystatin C expression in gliomas.
    Nakabayashi H; Hara M; Shimuzu K
    Hum Pathol; 2005 Sep; 36(9):1008-15. PubMed ID: 16153465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ezrin expression in tissue microarray of primary and recurrent gliomas.
    Tynninen O; Carpén O; Jääskeläinen J; Paavonen T; Paetau A
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):472-7. PubMed ID: 15488023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel molecular marker of pituitary tumor transforming gene involves in a rat liver regeneration.
    Akino K; Akita S; Mizuguchi T; Takumi I; Yu R; Wang XY; Rozga J; Demetriou AA; Melmed S; Ohtsuru A; Yamashita S
    J Surg Res; 2005 Nov; 129(1):142-6. PubMed ID: 15936773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cloning and characterization of human RTVP-1b, a novel splice variant of RTVP-1 in glioma cells.
    Xiang C; Sarid R; Cazacu S; Finniss S; Lee HK; Ziv-Av A; Mikkelsen T; Brodie C
    Biochem Biophys Res Commun; 2007 Oct; 362(3):612-8. PubMed ID: 17825796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PTTG mRNA expression in primary breast cancer: a prognostic marker for lymph node invasion and tumor recurrence.
    Solbach C; Roller M; Fellbaum C; Nicoletti M; Kaufmann M
    Breast; 2004 Feb; 13(1):80-1. PubMed ID: 14759723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.
    Bruna A; Darken RS; Rojo F; Ocaña A; Peñuelas S; Arias A; Paris R; Tortosa A; Mora J; Baselga J; Seoane J
    Cancer Cell; 2007 Feb; 11(2):147-60. PubMed ID: 17292826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.
    Hong X; Jiang F; Kalkanis SN; Zhang ZG; Zhang X; Zheng X; Mikkelsen T; Jiang H; Chopp M
    J Exp Ther Oncol; 2007; 6(3):219-29. PubMed ID: 17552362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome.
    Zolota V; Tsamandas AC; Aroukatos P; Panagiotopoulos V; Maraziotis T; Poulos C; Scopa CD
    Neuropathology; 2008 Feb; 28(1):35-42. PubMed ID: 18181833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation of a natural inhibitor of human malignant glial cell invasion: inter alpha-trypsin inhibitor heavy chain 2.
    Werbowetski-Ogilvie TE; Agar NY; Waldkircher de Oliveira RM; Faury D; Antel JP; Jabado N; Del Maestro RF
    Cancer Res; 2006 Feb; 66(3):1464-72. PubMed ID: 16452202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
    Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
    Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic changes of pituitary tumor-derived transforming gene 1 in pancreatic cancer.
    Zhang ML; Lu S; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):313-7. PubMed ID: 18522889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.